시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 탈회골기질 시장 보고서(2025년)
Demineralized Bone Matrix Global Market Report 2025
상품코드 : 1764296
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

탈회골기질 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 이 기간에 예상되는 주요 동향으로는 재생 의료의 발전, 탈회골기질와 줄기 세포 요법의 통합, 주사한 DBM 포맷의 개발, 합성 이식편과 하이브리드 이식편으로의 시프트, 특정의 용도에 맞춘 DBM의 커스터마이즈 등을 들 수 있습니다.

정형외과 질환의 유병률 상승은 향후 몇 년간의 탈회골기질 시장의 성장을 견인할 것으로 예측됩니다. 근골격계에 영향을 미치는 질환이 포함됩니다. 탈회골기질은 뼈 재생과 치유를 촉진하여 정형외과 치료를 지원하며 척추 고정술, 관절 재건술, 골절 수리에 필수적인 요소입니다. 성장을 가속하고 수술 결과를 개선하는 골 유도성 골격을 제공함으로써 회복을 촉진합니다. 예를 들어, 2023년 8월 미국의 공중 보건 연구 기관인 건강 측정 및 평가 연구소의 조사에 따르면 2023년 30세 이상 인구의 15%가 골관절염을 앓았으며, 2050년에는 그 수가 약 10억 명에 달할 것으로 예상됩니다.

탈회골기질 시장의 주요 기업은 3D 프린팅 뼈 매트릭스와 같은 첨단 제품 개발에 주력하고 있으며, 이는 정확성, 생체 적합성 및 재생 능력을 향상시킨 환자 고유의 골 이식을 가능하게 합니다. 3차원(3D) 프린트 뼈 매트릭스는 3D 프린팅 기술을 사용하여 천연 뼈 조직의 구조적 및 기능적 특성을 재현한 골격과 임플란트입니다. 예를 들어, 2022년 12월 미국의 생명공학 기업인 Essent Biologics는 3D 바이오프린팅 및 조직공학 응용 분야에 특화되어 설계된 미분화 뼈 기질을 발표했습니다. 이 혁신적인 제품은 바이오잉크와 골격에 쉽게 통합할 수 있는 표준화된 미분쇄 탈회골기질를 설명합니다. 세포의 접착과 성장을 가속하고 재생 치료 및 뼈 복구 접근법의 정확성과 효능을 향상시키는 생물학적 활성 및 맞춤형 구조물의 제조를 용이하게 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Demineralized bone matrix (DBM) is an allograft bone product created by removing the mineral content from human bone, leaving the organic collagen matrix and growth factors intact. This process retains proteins such as bone morphogenetic proteins (BMPs), which aid in promoting new bone growth. DBM is widely used in orthopedic and dental surgeries to facilitate bone healing and regeneration.

The main types of demineralized bone matrix products include gel, putty, sponge, fiber, paste, and others. Gel DBM is a formulation where the demineralized bone matrix is suspended in a biocompatible carrier like glycerol, hyaluronic acid, or saline-based solutions, resulting in a moldable and injectable gel-like texture. The tissue sources for DBM include allograft and xenograft materials, and it is utilized in various medical procedures such as dental, craniomaxillofacial, spinal fusion, long bone surgeries, joint reconstruction, and more. The key end users are hospitals, ambulatory surgical centers, specialty clinics, and others.

The demineralized bone matrix market research report is one of a series of new reports from The Business Research Company that provides demineralized bone matrix market statistics, including demineralized bone matrix industry global market size, regional shares, competitors with a demineralized bone matrix market share, detailed demineralized bone matrix market segments, market trends and opportunities, and any further data you may need to thrive in the demineralized bone matrix industry. This demineralized bone matrix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The demineralized bone matrix market size has grown strongly in recent years. It will grow from $1.05 billion in 2024 to $1.12 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. Growth during the historic period can be attributed to the rising incidence of orthopedic injuries, an increase in spinal fusion procedures, an expanding geriatric population, a growing preference for allografts, and a rise in sports-related injuries.

The demineralized bone matrix market size is expected to see strong growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. Growth during the forecast period can be attributed to the increasing demand for minimally invasive surgeries, rising healthcare expenditures, greater awareness among surgeons and patients, an enhanced focus on biologics in orthopedics, and a growing number of outpatient surgical centers. Key trends expected in this period include advancements in regenerative medicine, the integration of demineralized bone matrix with stem cell therapies, the development of injectable DBM formats, a shift toward synthetic and hybrid grafts, and customization of DBM for specific applications.

The rising prevalence of orthopedic disorders is expected to drive the growth of the demineralized bone matrix (DBM) market in the coming years. Orthopedic disorders encompass conditions affecting the musculoskeletal system, including bones, joints, muscles, ligaments, tendons, and nerves. The demand for orthopedic treatments is growing due to the aging global population, as older adults are more susceptible to musculoskeletal conditions such as osteoarthritis, osteoporosis, and fractures. Demineralized bone matrix supports orthopedic care by promoting bone regeneration and healing, making it a vital component in spinal fusion, joint reconstruction, and fracture repair. It enhances recovery by providing an osteoinductive scaffold that encourages natural bone growth and improves surgical outcomes. For example, in August 2023, a survey by the Institute for Health Metrics and Evaluation, a US-based public health research organization, reported that 15% of individuals aged 30 and above had osteoarthritis in 2023, with the number expected to reach approximately 1 billion by 2050. Thus, the increasing prevalence of orthopedic disorders is fueling growth in the DBM market.

Leading companies in the demineralized bone matrix market are concentrating on developing advanced products like 3D-printed bone matrices, which allow for patient-specific bone grafts with enhanced precision, biocompatibility, and regenerative capability. A three-dimensional (3D) printed bone matrix is a scaffold or implant created using 3D printing technology to replicate the structural and functional properties of natural bone tissue. For example, in December 2022, Essent Biologics, a US-based biotechnology firm, introduced a micronized bone matrix designed specifically for 3D bioprinting and tissue engineering applications. This innovative product offers a standardized, finely ground demineralized bone matrix that can be easily integrated into bioinks and scaffolds. It promotes cellular attachment and growth, facilitating the production of biologically active, customized constructs that enhance the accuracy and effectiveness of regenerative treatments and bone repair approaches.

In September 2023, Globus Medical Inc., a US-based medical device company, merged with NuVasive Inc. for an undisclosed sum. Through this merger, Globus Medical seeks to strengthen its leadership position in the global spine and orthopedics market by incorporating NuVasive's expertise in minimally invasive surgical techniques and advanced intraoperative technologies. NuVasive Inc., also based in the US, manufactures demineralized bone matrix (DBM) products under its Propel DBM brand.

Major players in the demineralized bone matrix market are Johnson & Johnson, Medtronic plc, Medline Industries LP, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Straumann AG, Globus Medical Inc., Integra LifeSciences Corporation, Halma plc, MTF Biologics, Exactech Inc., RTI Surgical, AlloSource, Cerapedics Inc., Keystone Dental Inc., Omnia Medical, Xtant Medical Holdings Inc., Hans Biomed Co. Ltd., and Bone Biologics Corp.

North America was the largest region in the demineralized bone matrix market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in demineralized bone matrix report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the demineralized bone matrix market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The demineralized bone matrix market consists of sales of puros demineralized bone matrix, bio-demineralized bone matrix (DBM), evograft, demineralized bone matrix chips, and demineralized bone matrix sheets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Demineralized Bone Matrix Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on demineralized bone matrix market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for demineralized bone matrix ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The demineralized bone matrix market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Demineralized Bone Matrix Market Characteristics

3. Demineralized Bone Matrix Market Trends And Strategies

4. Demineralized Bone Matrix Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Demineralized Bone Matrix Growth Analysis And Strategic Analysis Framework

6. Demineralized Bone Matrix Market Segmentation

7. Demineralized Bone Matrix Market Regional And Country Analysis

8. Asia-Pacific Demineralized Bone Matrix Market

9. China Demineralized Bone Matrix Market

10. India Demineralized Bone Matrix Market

11. Japan Demineralized Bone Matrix Market

12. Australia Demineralized Bone Matrix Market

13. Indonesia Demineralized Bone Matrix Market

14. South Korea Demineralized Bone Matrix Market

15. Western Europe Demineralized Bone Matrix Market

16. UK Demineralized Bone Matrix Market

17. Germany Demineralized Bone Matrix Market

18. France Demineralized Bone Matrix Market

19. Italy Demineralized Bone Matrix Market

20. Spain Demineralized Bone Matrix Market

21. Eastern Europe Demineralized Bone Matrix Market

22. Russia Demineralized Bone Matrix Market

23. North America Demineralized Bone Matrix Market

24. USA Demineralized Bone Matrix Market

25. Canada Demineralized Bone Matrix Market

26. South America Demineralized Bone Matrix Market

27. Brazil Demineralized Bone Matrix Market

28. Middle East Demineralized Bone Matrix Market

29. Africa Demineralized Bone Matrix Market

30. Demineralized Bone Matrix Market Competitive Landscape And Company Profiles

31. Demineralized Bone Matrix Market Other Major And Innovative Companies

32. Global Demineralized Bone Matrix Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Demineralized Bone Matrix Market

34. Recent Developments In The Demineralized Bone Matrix Market

35. Demineralized Bone Matrix Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기